NuVasive, Inc. (NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, reported second quarter net income of $10.3 million, or $0.20 per share, compared to a GAAP net loss of $4.1 million, or $0.09 per share, for the second quarter 2014. On a non-GAAP basis, the company reported net income of $15.7 million, or $0.31 per share, for the second quarter 2015.
On average, 19 analysts polled by Thomson Reuters expected the company to report profit per share of $0.25 for the quarter. Analysts' estimates typically exclude special items.
NuVasive reported second quarter 2015 total revenue of $202.9 million, a 6.4% increase compared to $190.7 million for the second quarter 2014. On a constant currency basis, second quarter 2015 total revenue increased 8.5% compared to the same period last year. Analysts expected revenue of $200.71 million for the quarter.
For full year 2015: the company expects revenue of approximately $810.0 million, or approximately 6.2% growth from 2014. On a constant currency basis revenue is expected to grow approximately 7.9%; versus a prior expectation of 7.8% for 2015. The company now expects GAAP earnings per share of approximately $1.18 versus a prior expectation of $1.12 for 2015. Non-GAAP earnings per share is expected to be approximately $1.17, versus a prior expectation of $1.10 for 2015. Analysts expect the company to report earnings per share of $1.12 on revenue of $812.22 million.
For comments and feedback contact: editorial@rttnews.com
Business News